REQUEST A DEMO
Total
USD $0.00
Search more companies

GeneFerm Biotechnology Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: GeneFerm Biotechnology Co., Ltd. Profile Updated: February 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

GeneFerm Biotechnology Co., Ltd. Established in 1999, GeneFerm Biotechnology Co., Ltd. is engaged in the production and sales of APIS intermediate and health foods. It also offers OEM serve.

Headquarters
No.33,Shin-Kung Rd, Shinying
Tainan City; Tainan City;

Contact Details: Purchase the GeneFerm Biotechnology Co., Ltd. report to view the information.

Website: http://www.geneferm.com

Basic Information
Total Employees:
Purchase the GeneFerm Biotechnology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the GeneFerm Biotechnology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the GeneFerm Biotechnology Co., Ltd. report to view the information.
Incorporation Date:
July 17, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
28.94%
Purchase this report to view the information.
5.17%
Purchase this report to view the information.
3.79%
Purchase this report to view the information.
2.05%
Purchase this report to view the information.
1.15%
Subsidiaries
GeneFerm International Development Co.,
Company Performance
Financial values in the chart are available after GeneFerm Biotechnology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
25.21%
Total operating revenue
25.57%
Operating profit (EBIT)
52.38%
EBITDA
41.97%
Net Profit (Loss) for the Period
33.35%
Total assets
-1.2%
Total equity
7.47%
Operating Profit Margin (ROS)
3.49%
Net Profit Margin
0.96%
Return on Equity (ROE)
2.71%
Debt to Equity Ratio
10.98%
Quick Ratio
0.31%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?